Literature DB >> 24002097

Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model.

A Stucki1, F Acosta, M Cottagnoud, P Cottagnoud.   

Abstract

In this study, the efficacy of ceftaroline fosamil was compared with that of cefepime in an experimental rabbit meningitis model against two Gram-negative strains (Escherichia coli QK-9 and Klebsiella pneumoniae 1173687). The penetration of ceftaroline into inflamed and uninflamed meninges was also investigated. Both regimens were bactericidal, but ceftaroline fosamil was significantly superior to cefepime against K. pneumoniae and E. coli in this experimental rabbit meningitis model (P < 0.0007 against K. pneumoniae and P < 0.0016 against E. coli). The penetration of ceftaroline was approximately 15% into inflamed meninges and approximately 3% into uninflamed meninges.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24002097      PMCID: PMC3837918          DOI: 10.1128/AAC.00285-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis.

Authors:  C T Fang; Y C Chen; S C Chang; W Y Sau; K T Luh
Journal:  QJM       Date:  2000-01

2.  Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  Philippe Cottagnoud; Cynthia M Gerber; Marianne Cottagnoud; Martin G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.

Authors:  C M Gerber; M Cottagnoud; K Neftel; M G Täuber; P Cottagnoud
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

4.  Microbiologic features of adult community-acquired bacterial meningitis in Taiwan.

Authors:  C T Fang; S C Chang; P R Hsueh; Y C Chen; W Y Sau; K T Luh
Journal:  J Formos Med Assoc       Date:  2000-04       Impact factor: 3.282

Review 5.  Strategy of Escherichia coli for crossing the blood-brain barrier.

Authors:  Kwang Sik Kim
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

6.  Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.

Authors:  A Louie; P Kaw; W Liu; N Jumbe; M H Miller; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

7.  Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program.

Authors:  Robert K Flamm; Helio S Sader; David J Farrell; Ronald N Jones
Journal:  Clin Infect Dis       Date:  2012-09       Impact factor: 9.079

8.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  Acute bacterial meningitis in adults. A review of 493 episodes.

Authors:  M L Durand; S B Calderwood; D J Weber; S I Miller; F S Southwick; V S Caviness; M N Swartz
Journal:  N Engl J Med       Date:  1993-01-07       Impact factor: 91.245

10.  Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults.

Authors:  C E Cherubin; J S Marr; M F Sierra; S Becker
Journal:  Am J Med       Date:  1981-08       Impact factor: 4.965

View more
  3 in total

1.  Ceftaroline Cerebrospinal Fluid Penetration in the Treatment of a Ventriculopleural Shunt Infection: A Case Report.

Authors:  Jeffrey J Cies; Wayne S Moore; Adela Enache; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2020

2.  Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance.

Authors:  Nicola Farrington; Laura McEntee; Adam Johnson; Jennifer Unsworth; Christopher Darlow; Ana Jimenez-Valverde; Christoph Hornik; Rachel Greenberg; Julie Schwartz; Shampa Das; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-03-22       Impact factor: 5.938

3.  Endogenous Endophthalmitis From Methicillin-Resistant Staphylococcus aureus Bacteremia Treated With Ceftaroline.

Authors:  Daniel Ho; Nicola A Clayton; Bruce Silverstein; Alan Koff
Journal:  Cureus       Date:  2022-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.